As NASA prepared astronauts for its second mission into space, National Geographic had exclusive behind-the-scenes access for ...

Max Verstappen ended second practice at the top of the timesheets, ahead of this weekend's Mexico City Grand Prix. Nine drivers missed first practice due to teams using Mexico as an opportunity to ...

Datavault AI has retained Paul Hastings LLP and Dickinson Wright PLLC to advise on litigation strategy and regulatory action. The Company is evaluating its legal rights and intends to pursue all ...

The "Drafting Winning Proposals for Legal, Commercial and Strategic Excellence Training Course (Jan 26th - Jan 27th, 2026)" training has been added to ResearchAndMarkets.com's offering. In today's ...

From sustainable finance and artificial intelligence to private equity and advanced hedge funds strategies, the University of Geneva’s Master of Advanced Studies in Finance (GEMFIN) covers a broad ...

Abstract: In this paper, a 226Ah type lithium-ion power battery module is taken as the research object, the temperature differences across various temperature sensor layout positions are studied, and ...

The 2025 Mexico City GP Free Practice 2 results saw Max Verstappen lay down an early marker in his first outing of the weekend to top of the timesheets at the Autodromo Hermanos Rodriguez in his Red ...

Max Verstappen returned to the Red Bull cockpit and set the fastest time in second practice for the Mexico City Grand Prix. The four-time Formula 1 champion was one of nine drivers to step aside for ...

A new peer-reviewed analysis shows K-12 students who got regular access to social and emotional learning had better test scores and better grades. There's been some debate about whether schools should ...

Across the country – and across the political spectrum – Americans see politically motivated violence as on the rise in the United States. How we did this Pew Research Center conducted this study to ...

The MSc Advanced Biomedical Science programme has been developed to address the evolving challenges in clinical laboratory ...

Takeda is paying Innovent Biologics $1.2 billion upfront for rights to two cancer candidates. The deal, which includes (PDF) $10.2 billion in milestones, puts the biologics at the center of Takeda’s ...